## **Trustees' Annual Report for the period**
||Period start date|Period start date|||Period end date|Period end date||
|---|---|---|---|---|---|---|---|
||6|APR|2022||5|APR|2023|
|**From**||||**To**||||
## Section A
## Reference and administration details
**Charity name Other names charity is known by Registered charity number (if any)** 1177093
TALK Foundation
**Charity's principal address** 12 Drysgol Road
Radyr Cardiff **Postcode CF15 8B T**
## **Names of the charity trustees who manage the charity**
|1
2
3
4
5
6
7
8|**Trustee name**|**Office (if any)**|**Dates acted if not for**
**whole year **|**Name of person (or body) entitled**
**to appoint trustee (ifany)**|
|---|---|---|---|---|
||Cristina Diaz- Navarro|Chair
(foundingmember)||N/A (first charity trustee)|
||Andrew Hadfield|Treasurer
(founding member)||N/A (first charity trustee)|
||Sonia Pierce|Secretary
(foundingmember)||N/A (first charity trustee)|
||Mark Price|Deputytreasurer||N/A(first charitytrustee)|
||Esther Leon Castelao|||N/A(first charitytrustee)|
||Sandrine Bacquaert|||N/A(first charitytrustee)|
||||||
||||||
||||||
## **Names of the trustees for the charity, if any, (for example, any custodian trustees)**
**Name Dates acted if not for whole year** N/A
## **Name of chief executive or names of senior staff members**
Mariam Paes - New Initiatives and Fundraising Director Rebecca Wheeler - Organisational Development Director (Until May 2022)
March **2012**
**TAR**
1
## **Section B**
## **Structure, governance and management**
## **Description of the charity’s trusts**
Constitution Type of governing document Registered 09 FEB 2018 (eg. trust deed, constitution) Charitable Incorporated Organisation How the charity is constituted (eg. trust, association, company) The three founding members will be indefinite trustees. The other 3 first Trustee selection methods trustees have been appointed for a period of 3 years and can be (eg. appointed by, elected by) reappointed up to 3 times.
Apart from the first charity trustees, every trustee must be appointed for a term of 3 years by a resolution passed at a properly convened meeting of the charity trustees.
## **Additional governance issues (Optional information)**
You **may choose** to include additional information, where relevant, about:
- policies and procedures adopted for the induction and training of trustees;
- the charity’s organisational structure and any wider network with which the charity works;
- relationship with any related parties;
- trustees’ consideration of major risks and the system and procedures to manage them.
The Organisation has the following Policies & Procedures in place: (The date following each title is the date of the latest revision, all available on request)
Affiliations Committee Terms of reference (May 2020) Business Plan (April 2021 –March 2024) Code of Conduct (October 2020) Conflicts of Interest (September 2020) Contractor Agreement (December 2020) Declaration on Appointment (April 2018) Disciplinary Procedure for Staff (April 2020) Disciplinary Policy and Procedure for Volunteers (April 2020) Education Committee Terms of reference (March 2020) Equality Policy (September 2020) Financial Controls Policy (January 2020) Fit and proper person declaration (April 2018) Fundraising Policy (March 2021) Memorandum of Understanding (May 2020) Privacy Statement (December 2021) Standard Operating Procedure for New Appointments (January 2022) TALK Research Committee Terms of reference (March 2020) TALK Foundation Constitution (2016) Volunteer management policy (March 2020)
March **2012**
**TAR**
2
## **Section C**
## **Objectives and activities**
|**Summary of the objects of the**
**charity set out in its**
**governing document**
**Summary of the main**
**activities undertaken for the**
**public benefit in relation to**
**these objects (include within**
**this section the statutory**
**declaration that trustees have**
**had regard to the guidance**
**issued by the Charity**
**Commission on public**
**benefit)**||For the public benefit to advance the education of clinical teams in patient
safety in such ways as the charity trustees think fit.
Our Vision, Mission and Values focus on maximising the opportunity for
healthcare improvement, patient safety and staff wellbeing through the
use of TALK, empowering a culture of patient safety through the
education of clinical teams ethically, inclusively and positively.
Meetings of the Board of Trustees have been held at least quarterly|
|---|---|---|
||~~and minutes are available on request~~.
The TALK Foundation hascontinued the activities undertaken as part
of theTALK Research and Innovation Staff Exchange grant provided by
the European Commission through the Horizon 2020 programme,
Marie Skłodowska-Curie Actions, which fundeda 3 year project on the
use of the TALK framework for clinical debriefing under grant
agreement ID: 734753. Thegrant project has been completed and the
TALK Foundation has continued the work. Theactivities have included:
- Development of freely downloadable training materials (https://
www.talkdebrief.org/startingtotalk )
- International diffusion of TALK concept (Implemented in the UK,
Spain, Norway, Denmark, Netherlands, Germany, France, Portugal,
Australia, Chile, Singapore, USA, Mexico and Argentina)
- Networking at a national and international level. As a consequence, a
strategy advisory board has been developed.
-Formalising collaboration and data-sharing
The TALK Foundation webpageis kept up to date https://
~~www.talkdebrief.org/talk-foundation ~~and the TALK Foundation bank
accountis managedthrough CAF Bank.
Trustees are aware of the Section 17(5) of the Charities Act and the
Charities (Accounts and Reports) Regulations 2008 and this has been
considered when planning the charity’s activities. Whilst it is
recognised that the TALK tool is a commercially viable product, the aim
of the Foundation is to ensure that any surplus is used for public rather
than personal benefit.||
March **2012**
**TAR**
3
## **Additional details of objectives and activities (Optional information)**
Th e emphasis has been on building a solid framework for the CIO, both with regard to organisational / legal guidance and volunteer workforce development.
You **may choose** to include further statements, where relevant, about:
- policy on grantmaking;
- policy programme related investment;
- contribution made by volunteers.
T he TALK Foundation is the legacy to the T ALK Research and Innovation Staff Exchange grant provided by the European Commission through the Horizon 2020 programme. This Marie Skłodowska-Curie Actions grant is funding a 3 year project on the use of the TALK framework for clinical debriefing under grant agreement ID: 734753. All materials and international network generated as outcomes of this work were passed on to the TALK Foundation at the end of the grant project, which was completed at the end of February 2022. The Foundation become fully independent of the grant in February 2022.
There has been significant and ongoing work in this report year to develop teaching courses in English and Spanish and to widen the International use of the TALK tool in clinical practice.
March **2012**
**TAR**
4
## Section D
## **Summary of the main achievements of the charity during the year**
## Achievements and performance
The Charity has focused on further defining the key services and activities offered by the Foundation and continued development of the resources to support these services and activities.
The TALK RISE project was completed in February 2022. Since then, during this financial year, t here has been an emphasis on international promotion of the Foundation, coinciding with the RISE phase of international dissemination.
The outcome of this dissemination has revealed the need to accelerate our infrastructural development, which has resulted in the further development of committees and divisions as well as the introduction of non voting members categories. (See details in organisational c hart, section B).
Previous achievements included development and review of Foundation documentation, as well as policies and procedures , as listed in Section B.
D - uring this financial year, we continued the work as detailed in the business plan (April 2021– March 2024) and made significant advances to the development of courses, to ensure the financial viability of the charity. The Fundraising Policy has been implemented.
There has been further development of the TALK website and memberships. Branding of the materials has been developed and implemented to ensure consistency in appearance of the materials.
There has been significant course development and initiation of a course management system - this includes educational materials / local training sessions for TALK, as well as an instructor guide. Many of the publications have been translated into Spanish.
There have been a number of international collaborations explored by the affiliations and research committees.
March **2012**
**TAR**
5
## **Section E**
## **Financial review**
**Brief statement of the charity’s policy on reserves**
The TALK Foundation does not currently have a policy on reserves. The charity is starting to raise initial funds for its activity. Development of a reserve policy will be a point for future action.
All reserves would be used to strengthen the financial basis of the charity in line with its stated objectives.
**Details of any funds materially in deficit**
None
## **Further financial review details (Optional information)**
You **may choose** to include additional information, where relevant about:
- the charity’s principal sources of funds (including any fundraising);
- how expenditure has supported the key objectives of the charity;
Current / potential sources of income:
- Donations
- Memberships
- Income from educational courses pertaining to the TALK clinical debriefing tool , from interested healthcare institutions .
- Grants applied for, from NGOs and specific philanthropic organisations with an interest in funding healthcare and patient safety (none received yet).
- investment policy and objectives including any ethical investment policy adopted.
## **Section F**
## **Other optional information**
## **Section G**
## **Declaration**
**The trustees declare that they have approved the trustees’ report above.**
**Signed on behalf of the charity’s trustees**
**Signature(s)**
**Full name(s** Dr Sonia Pierce Dr Cristina Diaz-Navarro **Position** Secretary Chair **Date** 26/01/2024 26/01/2024
March **2012**
**TAR**
6
|**TALK**|**FOUNDATION**|**FOUNDATION**||**1177093**||
|---|---|---|---|---|---|
||**Receipts andpayments accounts**||||**CC16a**|
|**For**|**the period**
**from**|4/4/2022|**To**|4/3/2023||
## **Section A Receipts and payments**
|**Section A Receipts and payments**|||||
|---|---|---|---|---|
|**A1 Receipts**
Course fees
**4,108**
Memberships
**818**
**-**
**-**
**-**
**-**
**-**
**-**
**4,926**
**-**
**-**
**_Sub total_ -**
**_Total receipts_ 4,926**
**A3 Payments**
Zoom meeting subscription
**144**
Bannk account fees
**72**
Website charges
**187**
Website domain
**110**
Website design services
**690**
**-**
**-**
**-**
**-**
**_Sub total_ 1,203**
**-**
**-**
**_Sub total_ -**
**_Total payments_ 1,203**
**_Net of receipts/(payments)_ 3,723**
**A5 Transfers between funds**
**-**
**A6 Cash funds last year end**
**3,990**
**_Cash funds this year end_ 7,713**
**Unrestricted**
**funds**
**to the nearest £**
**_Sub total_**_(Gross income for AR)_
**A2 Asset and investment sales,**
**(see table).**
**A4 Asset and investment**
**purchases, (see table)**|**to the nearest £**
**Restricted**
**funds**|**to the nearest £**
**Endowment**
**funds**|**Total funds**
**to the nearest £**|**Last year**
**to the nearest £**|
||**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**4,108**
**818**
**-**
**-**
**-**
**-**
**-**
**-**
**4,926**|**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
||||||
||**-**
**-**
**-**|**-**
**-**
**-**|**-**
**-**
**-**||
|||||**-**|
|||||**-**|
||||||
||**-**|**-**|**4,926**|**-**|
||||||
||**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**|**144**
**72**
**187**
**110**
**690**
**-**
**-**
**-**
**-**
**1,203**|**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
||||||
||**-**
**-**
**-**|**-**
**-**
**-**|**-**
**-**
**-**||
||||||
|||||**-**|
||||||
||**-**|**-**|**1,203**|**-**|
||||||
||**-**
**-**
**-**
**-**|**-**
**-**
**-**
**-**|**3,723**
**-**
**3,990**
**7,713**|**-**|
|||||**-**|
|||||**-**|
|||||**-**|
## **Section B Statement of assets and liabilities at the end of the period**
|**Categories**
**B1 Cash funds**
**B2 Other monetary assets**
**B3 Investment assets**
**B5 Liabilities**
**B4 Assets retained for the**
**charity’s own use**
Signed by one or two trustees on
behalf of all the trustees|**Details**
TALK Foundation Bank account balance
**Details**
**Details**
**Details**
**Details**
Signature
**_Total cash funds_**
(agree balances with receipts and payments
account(s))|**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**7,713**
**-**
OK
OK
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
Print Name
A. Hadfield
**Unrestricted**
**funds**
**Restricted**
**funds**
**Unrestricted**
**funds**
**Restricted**
**funds**
**Fund to which**
**asset belongs**
**Fund to which**
**asset belongs**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**|**to nearest £**
**Endowment**
**funds**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**to nearest £**
**Endowment**
**funds**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**
**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**
**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**
**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of
approval|
|||A. Hadfield|2/5/2024|
|||||